TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of routine laboratory tests ordered per patient-day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Exercise therapy compliance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Viral elimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Post operative analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in Migraine Headache Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with any Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: ratio of treatment change of FI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain in Children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of hypoglycemia warning system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participant Engagement (retention rate)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant Engagement (drop out)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Delivery of Intervention (Time with coach)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Spindle Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Standardized uptake values (SUVs) of 68Ga-ICAM-1pep at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in standardized uptake values (SUVs) of 68Ga-ICAM-1pep during radiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Difficulties in Emotion Regulation Scale (DERS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Emotion Dysregulation Inventory (EDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent change in frequency of seizures resulting in drops
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presence of enhancement of the optic nerve sheath on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Low contrast monocular visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: LURN SI-29 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: International Prostate Symptom Score-IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UROGENITAL DISTRESS INVENTORY- 6
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PHQ-9 total change from baseline to posttreatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to treatment discontinuation or death
Endpoint domain: Mortality/survival
Primary endpoint: Number of Unexpected Panic Attacks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Change in SBP from Baseline to Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pill Count Adherence Ratio (PCAR) at Month 12
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of stopping criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Composite variable poor prognosis (ICU & death)
Endpoint domain: Mortality/survival
Primary endpoint: Frequency and grade of unsolicited local and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of baseline postural stability test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of baseline diaphragm thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Height in z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mFARS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic and functional satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rate of peri-operative complication
Endpoint domain: Adverse events/effects
Primary endpoint: lipolytic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lipolysis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in smoking refusal self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of subjects achieving complete metabolic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects experiencing non-hematologic dose limiting toxicity (Mosunetuzumab)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects experiencing non-hematologic dose limiting toxicity (glofitimab)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects experiencing hematologic dose limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Reagents stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Wounds with Complete Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximum Observed Plasma/Serum Concentration (Cmax) Of ABBV-CLS-484
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Or Serum Concentration-Time Curve (AUC) Of ABBV-CLS-484
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) Of ABBV-CLS-484 Based On Response Evaluation Criteria In Solid Tumors (RECIST) v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores change from Baseline in the number symbol test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paternal Antenatal Attachment Scale-PAAS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: urinary function measured by ICIQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urinary function measured by EPIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urinary function measured by IPSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: sexual function measured by EPIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: sexual function measured by IIEF-5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: cardiac hemodynamic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 50% reduction in Severity of Alopecia Tool (SALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 50% reduction in Dermatology Life Quality Index (DLQI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Epilepsy susceptibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Solicited AEs during 7 days after experimental treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited AEs during 28 days after experimental treatment
Endpoint domain: Adverse events/effects
Primary endpoint: SAEs through 28 days after experimental treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical TCM scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Grading scores of Kellgren Lawrence (K-L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Difference in ADL score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of severe injection site reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of severe injection site reactions that are serious adverse events related to IP
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of treated responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavior on devaluation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting-state functional magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day point prevalence nicotine abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach tumor progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in knowledge, self-efficacy, and empathy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to death or becoming bedridden with permanent ventilatory support
Endpoint domain: Mortality/survival
Primary endpoint: Long-term outcomes after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychometric test (NST) results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glucose hydrogen breath test (BT) results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialysis Session Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ETMI Code
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of non-invasive ventilation (NIV) session
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of clinical-radiomic model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical erythema assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction rate of epileptic seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life perception
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vigilant Attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fatigue/alertness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Antibody titer reactogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of adverse pregnancy outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of CCTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event Survival
Endpoint domain: Mortality/survival
Primary endpoint: Auditory and vestibular functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of intraoperative oculocardiac reflex (OCR)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in HDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Therapeutic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily diary completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of Intervention Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified System Usability Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants developing local or systemic infection
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in the cardiovascular index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual Analogue Scale (VAS) - Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical Rating Scale (NRS) - Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-Form McGill Pain Questionnaire (SFMPQ) - Present Pain Intensity (PPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of intracranial clinical benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in radiographic horizontal ridge width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive improvement (Montreal Cognitive Assessment)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Performance on neuropsychological battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Accuracy of predictive test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Concordance of QSM signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of Talazoparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose limiting toxicity of Talazoparib
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with Minimal Clinically Important Improvement (MCII)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dissociative experiences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: procollagen type I carboxyl-terminal propeptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-density lipoprotein cholesterol/High-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Estradiol/follicle stimulating hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with successful procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Strength of Internal and External Rotator Muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of positive oral challenges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of eye fixations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of VR Exercises
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort of VR Headset
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Melatonin onset measured by self-collected saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melatonin onset measured by actigraphy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Caregiver's Global Health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Caregiver's Health Risk Behavior Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fecal secretory immune globulin A (sIgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mini Balance Evaluation System test (miniBEStest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity level measured by an accelerometer (MOX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight (for BMI calculation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Throwing velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline sleep quality index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change from baseline sleep duration and quality from diary
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: median weekly pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients global impression change scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with complete metabolic response or partial metabolic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with complete remission, complete remission with incomplete blood count recovery, complete remission with partial hematologic recovery, or morphologic leukemia free state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New stroke as assessed by the Pediatric NIH Stroke Scale (PedNIHSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in transcranial doppler (TCD) velocity by 15cm/sec or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: New or worsening cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change of scores EMOCARE
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of scores PHQ-9 self-administered
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metastases free survival
Endpoint domain: Mortality/survival
Primary endpoint: Syringe sales increase
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduced stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: linear deviation of inserted implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: angular deviation of inserted implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Superficial Electromyographic (EMG) Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static-Dynamic Balance Evaluation with Isokinetic Balance Device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Balance Evaluation with One Leg Standing Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual recurrence rate (ARR)
Endpoint domain: Mortality/survival
Primary endpoint: Number of successfully processed screening tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Shifts in cadence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Perception questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Non-inferiority of MRI compared to CT for pelvimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of gray matter volume of whole brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of white matter integrity of whole brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of verbal learning and memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SpO2 saturation measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Whole-body Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of General Movements
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pertussis antibody profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diphtheria antibody profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in Pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change from baseline in Paris questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in The Oswestry Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Leg muscular force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in blood oxygen level dependent (BOLD) response to visual food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in serum cortisol response to counting task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in horizontal bone thickness at the 3mm point from CEJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in horizontal bone thickness at the 6mm point from CEJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in horizontal bone thickness at the 9mm point from CEJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in volume of three dimensional bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in volume of three dimensional soft tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neck Disability Status Assessment (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Primary non-response to treatment with cyclosporine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes